Key details
Sponsor
Peking University Cancer Hospital & Institute
Enrollment target
~30 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated November 2024